{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:10:33Z","timestamp":1789049433277,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005744","name":"Lastentautien Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Biliary atresia (BA) is a chronic neonatal cholangiopathy characterized by fibroinflammatory bile duct damage. Reliable biomarkers for predicting native liver survival (NLS) following portoenterostomy (PE) surgery are lacking. Herein we explore the utility of 22 preidentified profibrotic molecules closely connected to ductular reaction (DR) and prevailing after successful PE (SPE), in predicting PE outcomes and liver injury. We used qPCR and immunohistochemistry in a BA cohort including liver samples obtained at PE (n\u2009=\u200953) and during postoperative follow-up after SPE (n\u2009=\u200925). Of the 13 genes over-expressed in relation to cholestatic age-matched controls at PE, only secretin receptor (<jats:italic>SCTR<\/jats:italic>) expression predicted cumulative 5-year NLS and clearance of jaundice. Patients in the highest <jats:italic>SCTR<\/jats:italic> expression tertile showed 34\u201355% lower NLS than other groups at 1\u20135\u00a0years after PE (<jats:italic>P<\/jats:italic>\u2009=\u20090.006\u20130.04 for each year). <jats:italic>SCTR<\/jats:italic> expression was also significantly lower [42 (24\u201363) vs 75 (39\u2013107) fold, <jats:italic>P<\/jats:italic>\u2009=\u20090.015] among those who normalized their serum bilirubin after PE. Liver SCTR expression localized in cholangiocytes and correlated positively with liver fibrosis, DR, and transcriptional markers of fibrosis (<jats:italic>ACTA2<\/jats:italic>) and cholangiocytes (<jats:italic>KRT7<\/jats:italic>, <jats:italic>KRT19<\/jats:italic>) both at PE and after SPE. SCTR is a promising prognostic marker for PE outcomes and associates with liver injury in BA.<\/jats:p>","DOI":"10.1038\/s41598-022-11140-9","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T10:04:08Z","timestamp":1651658648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Liver secretin receptor predicts portoenterostomy outcomes and liver injury in biliary atresia"],"prefix":"10.1038","volume":"12","author":[{"given":"Nimish","family":"Godbole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iiris","family":"Nyholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Hukkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tyraskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouko","family":"Lohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Heikkil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Eloranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjut","family":"Pihlajoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Heikinheimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Kyr\u00f6nlahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko P.","family":"Pakarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"11140_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/hep.29905","volume":"68","author":"JA Bezerra","year":"2018","unstructured":"Bezerra, J. A. et al. BILIARY ATRESIA: Clinical and research challenges for the 21st century. Hepatology 68, 1163\u20131173 (2018).","journal-title":"Hepatology"},{"key":"11140_CR2","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/S0140-6736(09)60946-6","volume":"374","author":"JL Hartley","year":"2009","unstructured":"Hartley, J. L., Davenport, M. & Kelly, D. A. Biliary atresia. The Lancet 374, 1704\u20131713 (2009).","journal-title":"The Lancet"},{"key":"11140_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005407","author":"X Lu","year":"2022","unstructured":"Lu, X. et al. Effect of adjuvant steroid therapy in type 3 biliary Atresia: A single-center, open-label, Randomized Controlled Trial. Ann. Surg. https:\/\/doi.org\/10.1097\/SLA.0000000000005407 (2022).","journal-title":"Ann. Surg."},{"key":"11140_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2021.101764","author":"M Hukkinen","year":"2021","unstructured":"Hukkinen, M., Ruuska, S., Pihlajoki, M., Kyr\u00f6nlahti, A. & Pakarinen, M. P. Long-term outcomes of biliary atresia patients surviving with their native livers. Best Pract. Res. Clin. Gastroenterol. https:\/\/doi.org\/10.1016\/j.bpg.2021.101764 (2021).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"11140_CR5","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S0140-6736(17)32284-5","volume":"390","author":"PKH Tam","year":"2017","unstructured":"Tam, P. K. H. et al. Advances in paediatric gastroenterology. Lancet 390, 1072\u20131082 (2017).","journal-title":"Lancet"},{"key":"11140_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/MOG.0000000000000509","volume":"35","author":"M Girard","year":"2019","unstructured":"Girard, M. & Panasyuk, G. Genetics in biliary atresia. Curr. Opin. Gastroenterol. 35, 73\u201381 (2019).","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"211\u2013217","key":"11140_CR7","first-page":"e1","volume":"170","author":"BL Shneider","year":"2016","unstructured":"Shneider, B. L. et al. Total Serum Bilirubin within 3 months of hepatoportoenterostomy predicts short-term outcomes in biliary atresia. J. Pediatr. 170(211\u2013217), e1-2 (2016).","journal-title":"J. Pediatr."},{"key":"11140_CR8","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jpedsurg.2012.10.010","volume":"48","author":"A Grieve","year":"2013","unstructured":"Grieve, A., Makin, E. & Davenport, M. Aspartate aminotransferase-to-platelet ratio index (APRi) in infants with biliary atresia: Prognostic value at presentation. J. Pediatr. Surg. 48, 789\u2013795 (2013).","journal-title":"J. Pediatr. Surg."},{"key":"11140_CR9","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1053\/j.gastro.2019.06.017","volume":"157","author":"Z Luo","year":"2019","unstructured":"Luo, Z., Shivakumar, P., Mourya, R., Gutta, S. & Bezerra, J. A. Gene expression signatures associated with survival times of pediatric patients with biliary atresia identify potential therapeutic agents. Gastroenterology 157, 1138-1152.e14 (2019).","journal-title":"Gastroenterology"},{"key":"11140_CR10","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/hep.29856","volume":"68","author":"J-F Wu","year":"2018","unstructured":"Wu, J.-F. et al. Transient elastography is useful in diagnosing biliary atresia and predicting prognosis after hepatoportoenterostomy. Hepatology 68, 616\u2013624 (2018).","journal-title":"Hepatology"},{"key":"11140_CR11","doi-asserted-by":"publisher","first-page":"e819","DOI":"10.1542\/neo.22-12-e819","volume":"22","author":"AG Feldman","year":"2021","unstructured":"Feldman, A. G. & Sokol, R. J. Neonatal cholestasis: Updates on diagnostics, therapeutics, and prevention. NeoReviews 22, e819\u2013e836 (2021).","journal-title":"NeoReviews"},{"key":"11140_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103689","volume":"74","author":"U Lendahl","year":"2021","unstructured":"Lendahl, U., Lui, V. C. H., Chung, P. H. Y. & Tam, P. K. H. Biliary Atresia-emerging diagnostic and therapy opportunities. EBioMedicine 74, 103689 (2021).","journal-title":"EBioMedicine"},{"key":"11140_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.sempedsurg.2020.150943","volume":"29","author":"M Hukkinen","year":"2020","unstructured":"Hukkinen, M., Pihlajoki, M. & Pakarinen, M. P. Predicting native liver injury and survival in biliary atresia. Semin. Pediatr. Surg. 29, 150943 (2020).","journal-title":"Semin. Pediatr. Surg."},{"key":"11140_CR14","doi-asserted-by":"publisher","first-page":"11692","DOI":"10.1038\/s41598-021-91072-y","volume":"11","author":"L He","year":"2021","unstructured":"He, L. et al. Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: A systematic review and meta-analysis. Sci. Rep. 11, 11692 (2021).","journal-title":"Sci. Rep."},{"key":"11140_CR15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/hep.30150","volume":"69","author":"K Sato","year":"2019","unstructured":"Sato, K. et al. Ductular reaction in liver diseases: Pathological mechanisms and translational significances. Hepatology 69, 420\u2013430 (2019).","journal-title":"Hepatology"},{"key":"11140_CR16","doi-asserted-by":"publisher","first-page":"G102","DOI":"10.1152\/ajpgi.00452.2016","volume":"313","author":"L Fabris","year":"2017","unstructured":"Fabris, L., Spirli, C., Cadamuro, M., Fiorotto, R. & Strazzabosco, M. Emerging concepts in biliary repair and fibrosis. Am. J. Physiol. Gastrointest Liver Physiol. 313, G102\u2013G116 (2017).","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"11140_CR17","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/hep4.1684","volume":"5","author":"A Kyr\u00f6nlahti","year":"2021","unstructured":"Kyr\u00f6nlahti, A. et al. Evolving up-regulation of biliary fibrosis-related extracellular matrix molecules after successful portoenterostomy. Hepatol. Commun. 5, 1036\u20131050 (2021).","journal-title":"Hepatol. Commun."},{"key":"11140_CR18","first-page":"10058","volume":"1","author":"S Afroze","year":"2013","unstructured":"Afroze, S. et al. The physiological roles of secretin and its receptor. Ann. Transl. Med. 1, 10058 (2013).","journal-title":"Ann. Transl. Med."},{"key":"11140_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1749-6632.2011.05987.x","volume":"1220","author":"Y Yuan","year":"2011","unstructured":"Yuan, Y., Lee, L. T. O., Ng, S. S. & Chow, B. K. C. Extragastrointestinal functions and transcriptional regulation of secretin and secretin receptors. Ann. N. Y. Acad. Sci. 1220, 23\u201333 (2011).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"11140_CR20","first-page":"G922","volume":"266","author":"G Alpini","year":"1994","unstructured":"Alpini, G. et al. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am. J. Physiol. 266, G922-928 (1994).","journal-title":"Am. J. Physiol."},{"key":"11140_CR21","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/hep.31484","volume":"72","author":"N Wu","year":"2020","unstructured":"Wu, N. et al. Functional role of the secretin\/secretin receptor signaling during cholestatic liver injury. Hepatology 72, 2219\u20132227 (2020).","journal-title":"Hepatology"},{"key":"11140_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/hep.23657","volume":"52","author":"S Glaser","year":"2010","unstructured":"Glaser, S. et al. Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation. Hepatology 52, 204\u2013214 (2010).","journal-title":"Hepatology"},{"key":"11140_CR23","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1016\/j.ajpath.2018.06.015","volume":"188","author":"N Wu","year":"2018","unstructured":"Wu, N. et al. The secretin\/secretin receptor axis modulates ductular reaction and liver fibrosis through changes in transforming growth factor-\u03b21-mediated biliary senescence. Am J Pathol 188, 2264\u20132280 (2018).","journal-title":"Am J Pathol"},{"key":"11140_CR24","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.28622","volume":"64","author":"N Wu","year":"2016","unstructured":"Wu, N. et al. The secretin\/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-\u03b21 biliary secretion in mice. Hepatology 64, 865\u2013879 (2016).","journal-title":"Hepatology"},{"key":"11140_CR25","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1096\/fj.201802606R","volume":"33","author":"L Kennedy","year":"2019","unstructured":"Kennedy, L. et al. Secretin\/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis. FASEB J. 33, 10269\u201310279 (2019).","journal-title":"FASEB J."},{"key":"11140_CR26","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399409000994","volume":"11","author":"SS Glaser","year":"2009","unstructured":"Glaser, S. S., Gaudio, E., Miller, T., Alvaro, D. & Alpini, G. Cholangiocyte proliferation and liver fibrosis. Expert Rev. Mol. Med. 11, e7 (2009).","journal-title":"Expert Rev. Mol. Med."},{"key":"11140_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jamcollsurg.2017.09.009","volume":"226","author":"M Hukkinen","year":"2018","unstructured":"Hukkinen, M. et al. Treatment policy and liver histopathology predict biliary atresia outcomes: Results after national centralization and protocol biopsies. J. Am. Coll. Surg. 226, 46-57.e1 (2018).","journal-title":"J. Am. Coll. Surg."},{"key":"11140_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/MCG.0000000000000013","volume":"48","author":"H Lampela","year":"2014","unstructured":"Lampela, H. et al. Native liver histology after successful portoenterostomy in biliary atresia. J. Clin. Gastroenterol. 48, 721\u2013728 (2014).","journal-title":"J. Clin. Gastroenterol."},{"key":"11140_CR29","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0022-3468(99)90652-8","volume":"34","author":"Y Kinugasa","year":"1999","unstructured":"Kinugasa, Y. et al. Bile ductular proliferation as a prognostic factor in biliary atresia: An immunohistochemical assessment. J. Pediatr. Surg. 34, 1715\u20131720 (1999).","journal-title":"J. Pediatr. Surg."},{"key":"11140_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jpedsurg.2008.09.013","volume":"44","author":"JL Santos","year":"2009","unstructured":"Santos, J. L. et al. The extent of biliary proliferation in liver biopsies from patients with biliary atresia at portoenterostomy is associated with the postoperative prognosis. J. Pediatr. Surg. 44, 695\u2013701 (2009).","journal-title":"J. Pediatr. Surg."},{"key":"11140_CR31","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/febs.13665","volume":"283","author":"I Fabregat","year":"2016","unstructured":"Fabregat, I. et al. TGF-\u03b2 signalling and liver disease. FEBS J. 283, 2219\u20132232 (2016).","journal-title":"FEBS J."},{"key":"11140_CR32","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","volume":"16","author":"H-Z Ying","year":"2017","unstructured":"Ying, H.-Z. et al. PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics. Mol. Med. Rep. 16, 7879\u20137889 (2017).","journal-title":"Mol. Med. Rep."},{"key":"11140_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.surg.2018.12.003","volume":"165","author":"A Kerola","year":"2019","unstructured":"Kerola, A. et al. Divergent expression of liver transforming growth factor superfamily cytokines after successful portoenterostomy in biliary atresia. Surgery 165, 905\u2013911 (2019).","journal-title":"Surgery"},{"key":"11140_CR34","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jpedsurg.2004.01.030","volume":"39","author":"S-Y Lee","year":"2004","unstructured":"Lee, S.-Y. et al. Identification of transforming growth factors actively transcribed during the progress of liver fibrosis in biliary atresia. J. Pediatr. Surg. 39, 702\u2013708 (2004).","journal-title":"J. Pediatr. Surg."},{"key":"11140_CR35","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.ajpath.2019.03.012","volume":"189","author":"Y-F Pei","year":"2019","unstructured":"Pei, Y.-F., Liu, J., Cheng, J., Wu, W.-D. & Liu, X.-Q. Silencing of LAMC2 reverses epithelial-mesenchymal transition and inhibits angiogenesis in cholangiocarcinoma via inactivation of the epidermal growth factor receptor signaling pathway. Am. J. Pathol. 189, 1637\u20131653 (2019).","journal-title":"Am. J. Pathol."},{"key":"11140_CR36","doi-asserted-by":"crossref","first-page":"101042831770584","DOI":"10.1177\/1010428317705849","volume":"39","author":"D Huang","year":"2017","unstructured":"Huang, D., Du, C., Ji, D., Xi, J. & Gu, J. Overexpression of LAMC2 predicts poor prognosis in colorectal cancer patients and promotes cancer cell proliferation, migration, and invasion. Tumour. Biol. 39, 1010428317705849 (2017).","journal-title":"Tumour. Biol."},{"key":"11140_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/hep.27045","volume":"60","author":"K Bessho","year":"2014","unstructured":"Bessho, K. et al. Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease. Hepatology 60, 211\u2013223 (2014).","journal-title":"Hepatology"},{"key":"11140_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00441-009-0838-2","volume":"339","author":"M Durbeej","year":"2010","unstructured":"Durbeej, M. Laminins. Cell Tissue Res. 339, 259\u2013268 (2010).","journal-title":"Cell Tissue Res."},{"key":"11140_CR39","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jhep.2020.06.012","volume":"73","author":"RO Babu","year":"2020","unstructured":"Babu, R. O. et al. Beta-amyloid deposition around hepatic bile ducts is a novel pathobiological and diagnostic feature of biliary atresia. J. Hepatol. 73, 1391\u20131403 (2020).","journal-title":"J. Hepatol."},{"key":"11140_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/hep4.1306","volume":"3","author":"M Hukkinen","year":"2019","unstructured":"Hukkinen, M. et al. Noninvasive evaluation of liver fibrosis and portal hypertension after successful portoenterostomy for biliary atresia. Hepatol. Commun. 3, 382\u2013391 (2019).","journal-title":"Hepatol. Commun."},{"key":"11140_CR41","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"C-T Wai","year":"2003","unstructured":"Wai, C.-T. et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38, 518\u2013526 (2003).","journal-title":"Hepatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11140-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:32:27Z","timestamp":1669343547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11140-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["11140"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-11140-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"1 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7233"}}